Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD
CompletedOBSERVATIONAL
Enrollment
292
Participants
Timeline
Start Date
March 18, 2021
Primary Completion Date
April 30, 2025
Study Completion Date
April 30, 2025
Conditions
NAFLD
Trial Locations (1)
31 076
Clinique Pasteur, Toulouse
All Listed Sponsors
lead
Clinique Pasteur
OTHER
NCT04774302 - Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD | Biotech Hunter | Biotech Hunter